日韩在线人妻伊人|亚洲美女屁股眼交一区二区|精品国产按摩aaa国产精品|美女网站黄色亚洲|www污污污久久|老熟女另类一区一一区|欧美 亚洲 无码|牛牛成人三级电影|精品欧美国产日本懒草在线|先锋影音国内自拍

Sorry, you are not login!
VIP members can check the contents after login.
Click to login

  • TOP
  • Moblie
    All Prompt Messages

    Tradesns Foreign Trade Community
    Current page location: Home Page > Article > Jack ma: a trade war is like treating the flu with chemotherapy
    Jack ma: a trade war is like treating the flu with chemotherapy
    Browse volume:443 | Reply:0 | Release time:2018-04-12 08:57:34

    It's normal for the world's two biggest economies to have problems with trade, but tackling them with a trade war is just like treating a flu with chemotherapies,founder and chairman of Chinese e-commerce giant Alibaba Group Jack Ma said Monday.

    "You are not solving the problem of the cold, you are destroying the whole body, the whole system," Ma made the comment while attending a dinner with International Monetary Fund Managing Director Christine Lagarde during the Boao Forum for Asia annual conference, which runs from April 8 to 11.

    Ma said that trade is about mutual respect and that nobody can stop globalization. "Trade is about rules and negotiation. If trade stops, war starts," he said.
     
    Speaking of the U.S.-China trade deficit, Ma dismissed the issue as a problem, citing economic growth and a low jobless rate in the United States as well as huge profit made by U.S. firms in the bilateral trade.
     
    "Today as a businessman, I don't feel that trade deficit is a problem," he said.
     
    For her part, Lagarde also warned of the risk of temptation for inward policies, protectionism and closing off to the outside world.
     
    She suggested reducing trade barriers in the service industry where there is "a big, big upside" in promoting openness.
     
    The managing director also cautioned challenges to the global economy, including corporate debt and demographic change, saying that "the sun is shining, but we have to look at the cloud arising."
    Concern (0
    Commentary(0)
    Share
    Popular
    Relevant